A citation-based method for searching scientific literature

D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude, H Sobol, M D Teare, J Struewing, A Arason, S Scherneck, J Peto, T R Rebbeck, P Tonin, S Neuhausen, R Barkardottir, J Eyfjord, H Lynch, B A Ponder, S A Gayther, M Zelada-Hedman. Am J Hum Genet 1998
Times Cited: 2144

Mary-Claire King, Joan H Marks, Jessica B Mandell. Science 2003
Times Cited: 1490

List of shared articles

Times cited

Clinicopathological features and BRCA1 and BRCA2 mutation status in a prospective cohort of young women with breast cancer.
Yaileen D Guzmán-Arocho, Shoshana M Rosenberg, Judy E Garber, Hilde Vardeh, Philip D Poorvu, Kathryn J Ruddy, Gregory Kirkner, Craig Snow, Rulla M Tamimi, Jeffrey Peppercorn,[...]. Br J Cancer 2022

Modification of BRCA1-associated breast cancer risk by HMMR overexpression.
Francesca Mateo, Zhengcheng He, Lin Mei, Gorka Ruiz de Garibay, Carmen Herranz, Nadia García, Amanda Lorentzian, Alexandra Baiges, Eline Blommaert, Antonio Gómez,[...]. Nat Commun 2022

Homologous recombination deficiency in breast cancer: Implications for risk, cancer development, and therapy.
Rayhaan M M Ali, Stuart A McIntosh, Kienan I Savage. Genes Chromosomes Cancer 2021

Decision aids for female BRCA mutation carriers: a scoping review protocol.
Sarah A McGarrigle, Geraldine Prizeman, Carol Spillane, Niamh Byrne, Amanda Drury, David Mockler, Elizabeth M Connolly, Anne-Marie Brady, Yvonne P Hanhauser. BMJ Open 2021

Efficacy of risk-reducing salpingo-oophorectomy in BRCA1-2 variants and clinical outcomes of follow-up in patients with isolated serous tubal intraepithelial carcinoma (STIC).
Carlo Saccardi, Stefania Zovato, Giulia Spagnol, Giulio Bonaldo, Matteo Marchetti, Lara Alessandrini, Silvia Tognazzo, Angela Guerriero, Amerigo Vitagliano, Antonio Simone Laganà,[...]. Gynecol Oncol 2021

Peutz-Jeghers Syndrome and the Role of Imaging: Pathophysiology, Diagnosis, and Associated Cancers.
Sergio Klimkowski, Mohamed Ibrahim, Juan J Ibarra Rovira, Mohamed Elshikh, Sanaz Javadi, Albert R Klekers, Abdelraham A Abusaif, Ahmed W Moawad, Kamran Ali, Khaled M Elsayes. Cancers (Basel) 2021

BRCA1/BRCA2 Pathogenic Variant Breast Cancer: Treatment and Prevention Strategies.
Anbok Lee, Byung In Moon, Tae Hyun Kim. Ann Lab Med 2020

Efficacy and safety of PARP inhibitors as the maintenance therapy in ovarian cancer: a meta-analysis of nine randomized controlled trials.
Fengping Shao, Jun Liu, Yaoyun Duan, Li Li, Liqun Liu, Cai Zhang, Shanyang He. Biosci Rep 2020

Precision Medicine and the Role of Biomarkers of Radiotherapy Response in Breast Cancer.
James Meehan, Mark Gray, Carlos Martínez-Pérez, Charlene Kay, Lisa Y Pang, Jennifer A Fraser, Amy V Poole, Ian H Kunkler, Simon P Langdon, David Argyle,[...]. Front Oncol 2020

Naturally-Occurring Canine Mammary Tumors as a Translational Model for Human Breast Cancer.
Mark Gray, James Meehan, Carlos Martínez-Pérez, Charlene Kay, Arran K Turnbull, Linda R Morrison, Lisa Y Pang, David Argyle. Front Oncol 2020

PRIMPOL-Mediated Adaptive Response Suppresses Replication Fork Reversal in BRCA-Deficient Cells.
Annabel Quinet, Stephanie Tirman, Jessica Jackson, Saša Šviković, Delphine Lemaçon, Denisse Carvajal-Maldonado, Daniel González-Acosta, Alexandre T Vessoni, Emily Cybulla, Matthew Wood,[...]. Mol Cell 2020

Clinicopathological features of women with epithelial ovarian cancer and double heterozygosity for BRCA1 and BRCA2: A systematic review and case report analysis.
Cécile Le Page, Kurosh Rahimi, Manuel Rodrigues, Viola Heinzelmann-Schwarz, Neil Recio, Stefania Tommasi, Guillaume Bataillon, Lise Portelance, Lisa Golmard, Liliane Meunier,[...]. Gynecol Oncol 2020